Mizoribine clinical trials
Also written HE-69.
How each study uses mizoribine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the mizoribine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2014 (2)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 2 |
| 2022 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Asahi Kasei Pharma Corporation (2) · Lee's Pharmaceutical Limited (2) · Chong Kun Dang Pharmaceutical (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses mizoribine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation RecipientsRecruitingPhase 4Lee's Pharmaceutical LimitedNCT06114953Written as MizoribineHow we know
- An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant RecipientsStatus unknownPhase 4Lee's Pharmaceutical LimitedNCT05293704Written as MizoribineHow we know
- A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus NephritisCompletedPhase 3Asahi Kasei Pharma CorporationNCT02256150Written as Mizoribine (MZR)How we know
- A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic SyndromeCompletedPhase 3Asahi Kasei Pharma CorporationNCT02257697Written as Mizoribine (MZR)How we know
- Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)Status unknownPhase 2Chong Kun Dang PharmaceuticalNCT02005757Written as Bredinin tablet 150mgHow we know
Given beside what is tested · 1 — mizoribine is usual care or a partner of the new treatment
Codes
What other systems call mizoribine · ClinicalTrials.gg INT002476
- MeSH (NLM) C010052mizoribineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 4JR41A10VPMIZORIBINEConfirmed FDA, NLM, Wikidata
- Wikidata Q6884708mizoribineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66172MizoribineOne source FDA
- DrugBank DB12617One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C010052 | mizoribine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 4JR41A10VP | MIZORIBINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q6884708 | mizoribine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66172 | Mizoribine | One source FDA |
| DrugBank | DB12617 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.